Related Experiment Videos
Prevention and management of RhD isoimmunization
Ursula F Harkness1, Joseph A Spinnato
1Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, University of Cincinnati, 231 Albert Sabin Way, PO Box 670526, Cincinnati, OH 45267-0526, USA. ursula.harkness@uc.edu
Clinics in Perinatology
|November 3, 2004
Summary
Rh-negative mothers face Rh isoimmunization risk from Rh-positive babies. Early detection and intervention, using Doppler and amniotic fluid analysis, improve fetal outcomes.
Area of Science:
- Maternal-Fetal Medicine
- Immunology
- Neonatology
Background:
- Rh isoimmunization occurs when Rh-negative mothers are exposed to Rh-positive fetal blood.
- Rh immune globulin, introduced in 1968, has significantly reduced Rh isoimmunization and hemolytic disease incidence.
- Despite prophylaxis, RhD sensitization can still occur, necessitating careful management.
Purpose of the Study:
- To review the diagnosis and management of Rh isoimmunization in pregnancy.
- To highlight the importance of monitoring and intervention for affected pregnancies.
- To discuss diagnostic tools for fetal anemia.
Main Methods:
- Review of literature on Rh isoimmunization and its management.
- Discussion of diagnostic techniques including Doppler assessment and amniotic fluid analysis.
- Emphasis on follow-up protocols for Rh-sensitized pregnancies.
Main Results:
- Rh immune globulin prophylaxis has dramatically decreased the incidence of Rh isoimmunization.
- When sensitization occurs, timely intervention and monitoring lead to favorable outcomes in most cases.
- Doppler assessment of middle cerebral artery peak systolic velocity and DeltaOD 450 are effective diagnostic tools for fetal anemia.
Conclusions:
- Rh isoimmunization remains a concern, but its incidence is low due to effective prophylaxis.
- Careful maternal and fetal monitoring are crucial for managing Rh-sensitized pregnancies.
- Advanced diagnostic methods aid in timely intervention and improved fetal health outcomes.